Literature DB >> 21901857

Clinical predictors of nasal continuous positive airway pressure requirement in acute bronchiolitis.

Jordan Evans1, Matko Marlais, Ed Abrahamson.   

Abstract

INTRODUCTION: There is growing use of nasal continuous positive airway pressure ventilation (nCPAP) for infants with bronchiolitis, based on clinical assessment of severity. Despite this there have been no studies which identify clinical predictors for the requirement of nCPAP.
OBJECTIVE: To identify clinical factors in infants with acute bronchiolitis in the emergency department (ED), which might predict a requirement for nCPAP following admission.
MATERIALS AND METHODS: Retrospective review of pediatric ED case notes was conducted on bronchiolitis admissions to one dedicated Paediatric ED over a 12-month period. Potential predictors were identified through literature review. Data extraction of predictors was carried out and recorded for each case. Logistic regression was conducted for each variable to identify statistically significant predictors of nCPAP requirement.
RESULTS: Twenty-eight (17%) of the 163 admitted infants received nCPAP. The strongest predictors of nCPAP requirement in were as follows: oxygen requirement within the ED (P < 0.001), lower oxygen saturation (P < 0.001), younger age at presentation (P = 0.002), higher respiratory rate (P = 0.002), higher heart rate (P = 0.003), lower Glasgow Coma Scale score (0.006), and younger gestational age (P = 0.024).
CONCLUSION: We have identified clinical variables that were predictive of nCPAP requirement in infants admitted to our unit with bronchiolitis, oxygen requirement in the ED being the strongest single predictor. This is the first such study in the UK, and we hope it may be a starting point for further work that may provide an evidence base to aid clinicians in predicting the use of nCPAP in infants with bronchiolitis.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901857     DOI: 10.1002/ppul.21549

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

1.  Comparison of a high-flow humidified nasal cannula to nasal continuous positive airway pressure in children with acute bronchiolitis: experience in a pediatric intensive care unit.

Authors:  Prune Metge; Céline Grimaldi; Sophie Hassid; Laurent Thomachot; Anderson Loundou; Claude Martin; Fabrice Michel
Journal:  Eur J Pediatr       Date:  2014-02-14       Impact factor: 3.183

2.  Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation.

Authors:  Jonathan M Mansbach; Pedro A Piedra; Michelle D Stevenson; Ashley F Sullivan; Tate F Forgey; Sunday Clark; Janice A Espinola; Carlos A Camargo
Journal:  Pediatrics       Date:  2012-08-06       Impact factor: 7.124

3.  A simple respiratory severity score that may be used in evaluation of acute respiratory infection.

Authors:  Hector Rodriguez; Tina V Hartert; Tebeb Gebretsadik; Kecia N Carroll; Emma K Larkin
Journal:  BMC Res Notes       Date:  2016-02-12

4.  Healthcare cost attributable to bronchiolitis: A population-based cohort study.

Authors:  Beate Sander; Yaron Finkelstein; Hong Lu; Chenthila Nagamuthu; Erin Graves; Lauren C Ramsay; Jeffrey C Kwong; Suzanne Schuh
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

5.  Characterizing Avoidable Transfer Admissions in Infants Hospitalized for Bronchiolitis.

Authors:  Tehnaz P Boyle; Charles G Macias; Susan Wu; Sara Holmstrom; Larissa L Truschel; Janice A Espinola; Ashley F Sullivan; Carlos A Camargo
Journal:  Hosp Pediatr       Date:  2020-04-08

Review 6.  Acute bronchiolitis in infants, a review.

Authors:  Knut Øymar; Håvard Ove Skjerven; Ingvild Bruun Mikalsen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-04-03       Impact factor: 2.953

7.  Continuous positive airway pressure for bronchiolitis in a general paediatric ward; a feasibility study.

Authors:  Knut Oymar; Kjersti Bårdsen
Journal:  BMC Pediatr       Date:  2014-05-12       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.